Coupling syringe system comprising drug nanosuspension and photo-crosslinked gelatin methacryloyl hydrogel for subcutaneous delivery with decreased initial exposure
Source abstract
Abstract
A novel, ready-to-use coupling syringe system comprising drug nanosuspensions (NSs) and photo-crosslinked gelatin methacryloyl (GelMA) hydrogels was constructed for prolonged subcutaneous drug delivery with reduced initial burst release. Three poorly water-soluble drugs—dutasteride (DTS), donepezil (DNP), and rotigotine (RTG)—were formulated into uniform NSs using a bead milling process, with mean particle sizes of 371.3, 338.7, and 769.2 nm, respectively. GelMA hydrogels were synthesized via photo-crosslinking with eosin Y and triethanolamine as initiators, adjusting rheological properties, swelling behavior, and biodegradation rates. The DTS-, DNP-, and RTG-loaded NSs were uniformly incorporated into GelMA hydrogels using a two-syringe mixing process, resulting in significantly sustained in vitro drug release under sink conditions and localized in vivo retention at the injection sites. Notably, NS-loaded GelMA hydrogels showed reduced initial systemic exposure compared to NS alone, while achieving comparable overall systemic exposure following a single subcutaneous injection in rats. This ready-to-use hydrogel system offers a simple and effective platform for parenteral delivery, addressing the limitations of conventional nanosystems associated with burst release.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Hydrogels: synthesis, properties, applications · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (86)
Show source-provided references
1. Patient-centric long-acting injectable and implantable platforms – an industrial perspective
2. Impact of jet pulverization and wet milling techniques on properties of aripiprazole long-acting injection and absorption mechanism research in vivo
3. Comparison of in vivo behaviors of intramuscularly long acting celecoxib nanosuspensions with different particle sizes for the postoperative pain treatment10.1016/j.ijpharm.2023.122793 ↗
4. Predicting the temperature evolution during nanomilling of drug suspensions via a semi theoretical lumped parameter model10.3390/pharmaceutics14122840 ↗
5. Nanocrystals based pulmonary inhalation delivery system: advance and challenge10.1080/10717544.2022.2039809 ↗
6. Emerging role of nanosuspensions in drug delivery systems10.1186/s40824-020-0184-8 ↗
7. Nanocrystals and nanosuspensions: an exploration from classic formulations to advanced drug delivery systems10.1007/s13346-024-01559-0 ↗
8. Understanding the burst release phenomenon: toward designing effective nanoparticulate drug-delivery systems10.4155/tde-2020-0099 ↗
9. Overcoming barriers by local drug delivery with liposomes10.1016/j.addr.2021.01.019 ↗
10. Internal-external homologous drug-loaded exosome-like nanovesicles released from semi-IPN hydrogel enhancing wound healing of chemoradiotherapy-induced oral mucositis10.2147/IJN.S508530 ↗
11. 5-Fluorouracil-loaded green chitosan nanoparticles/guar gum nanocomposite hydrogel in controlled drug delivery10.1016/j.carres.2024.109257 ↗
12. Fabrication of lipid-modified drug nanocrystals loaded injectable hydrogel for breast cancer therapy10.1186/s11671-025-04195-w ↗
13. New insights into nanocomposite hydrogels; a review on recent advances in characteristics and applications
14. Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection10.1016/j.carbpol.2024.122546 ↗
15. Biomedical applications of functional hydrogels: innovative developments, relevant clinical trials and advanced products10.1016/j.biomaterials.2024.122718 ↗
16. Regenerative medicine: hydrogels and mesoporous silica nanoparticles
17. In-situ forming PLGA implants: towards less toxic solvents10.1016/j.ijpharm.2024.124121 ↗
18. Long-acting injectable delivery system comprising ordered mixed drug aggregates with deaggregating and uniformly embeddable viscoelastic -polysaccharide solutions10.1016/j.carbpol.2025.123682 ↗
19. Microcrystal delivery using a syringe and syringe pump method for serial crystallography10.3390/analytica6010005 ↗
20. Injectable in-situ forming depot based on PLGA and PLGA-PEG-PLGA for sustained-release of risperidone: in vitro evaluation and pharmacokinetics in rabbits10.3390/pharmaceutics15041229 ↗
21. An overview on common organic solvents and their toxicity10.9734/jpri/2019/v28i330203 ↗
22. Exposure to the bromodomain inhibitor N-methyl pyrrolidone blocks spermatogenesis in a hormonal and non-hormonal fashion10.1016/j.taap.2021.115568 ↗
23. Unveiling the versatility of gelatin methacryloyl hydrogels: a comprehensive journey into biomedical applications10.1088/1748-605X/ad4df7 ↗
24. Photocrosslinkable gelatin hydrogel for epidermal tissue engineering10.1002/adhm.201500005 ↗
25. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels10.1016/j.biomaterials.2015.08.045 ↗
26. R.N. Ghosh, J. Thomas, V.B. R., N.G. Devi, A. Janardanan, P.K. Namboothiri, M. Peter, An insight into synthesis, properties and applications of gelatin methacryloyl hydrogel for 3D bioprinting, Mater. Adv. 4 (2023) 5496–5529. https://doi.org/10.1039/D3MA00715D.10.1039/D3MA00715D ↗
27. Gelatin methacryloyl hydrogels control the localized delivery of albumin-bound paclitaxel10.3390/polym12020501 ↗
28. GelMA–based bioactive hydrogel scaffolds with multiple bone defect repair functions: therapeutic strategies and recent advances10.1186/s40824-023-00422-6 ↗
29. Avodart® FDA Biopharmaceutics Review, Available online: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21319_Duagen_biopharmr_P1.pdf (accessed June 17, 2025).
30. Donepezil—an updated review of challenges in dosage form design
31. Rotigotine: a review of analytical methods for the raw material, pharmaceutical formulations, and its impurities10.1093/jaoacint/qsaa145 ↗
32. U.S. Food and Drug Administration, Aricept® (donepezil hydrochloride) (NDA 020690 & 021720 & 022568), 1996. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf.
33. U.S. Food and Drug Administration, Neupro® (rotigotine transdermal system) (NDA 021829), 2012. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/021829Orig1s001s002.pdf.
34. Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies10.1371/journal.pone.0114835 ↗
35. Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study10.1016/j.jsps.2016.04.022 ↗
36. Preparation and evaluation of injectable microsphere formulation for longer sustained release of donepezil10.1016/j.jconrel.2023.02.024 ↗
37. Suspected donepezil toxicity: a case report10.1002/ccr3.3245 ↗
38. Dissolving microarray patches loaded with a rotigotine nanosuspension: a potential alternative to Neupro® patch10.1016/j.jconrel.2024.06.039 ↗
39. Carboxymethyl cellulose-based rotigotine nanocrystals-loaded hydrogel for increased transdermal delivery with alleviated skin irritation10.1016/j.carbpol.2024.122197 ↗
40. In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels10.1039/C7BM00110J ↗
41. Tuning gelatin-based hydrogel towards bioadhesive ocular tissue engineering applications
42. Ionic effects on the mechanical and swelling properties of a poly(acrylic acid/acrylamide) double crosslinking hydrogel10.1039/C8NJ00920A ↗
43. Enzymatic post-crosslinking of printed hydrogels of methacrylated gelatin and tyramine-conjugated 8-arm poly(ethylene glycol) to prepare interpenetrating 3D network structures10.18063/ijb.750 ↗
44. Single color digital H&E staining with In-and-out net
45. A method to monitor dutasteride in rat plasma using liquid-liquid extraction and multiple reaction monitoring: comparisons and validation10.5478/MSL.2014.5.3.79 ↗
46. Optimized method development and validation for determining donepezil in rat plasma: a liquid–liquid extraction, LC–MS/MS, and design of experiments approach10.1371/journal.pone.0309802 ↗
47. A sensitive, efficient, and cost-effective method to determine rotigotine in rat plasma using liquid-liquid extraction (LLE) and LC-MRM
48. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
49. Engineering biodegradable and biocompatible bio-ionic liquid conjugated hydrogels with tunable conductivity and mechanical properties10.1038/s41598-017-04280-w ↗
50. Visible light photoinitiation of mesenchymal stem cell-laden bioresponsive hydrogels10.22203/eCM.v022a04 ↗
51. Yield-stress and creep control depot formation and persistence of injectable hydrogels following subcutaneous administration10.1002/adfm.202203402 ↗
52. Engineering the viscoelasticity of gelatin methacryloyl (GelMA) hydrogels via small “dynamic bridges” to regulate BMSC behaviors for osteochondral regeneration
53. Eosin Y derivatives for visible light-mediated free-radical polymerization: applications in 3D-photoprinting and bacterial photodynamic inactivation10.1016/j.eurpolymj.2024.113143 ↗
54. Role of polymer concentration and crosslinking density on release rates of small molecule drugs10.3390/ijms23084118 ↗
55. A recent overview of surfactant–drug interactions and their importance10.1039/D3RA02883F ↗
56. Preparation of carbohydrate-based functional composite films incorporated with curcumin10.1016/j.foodhyd.2019.105302 ↗
57. Y. Zhang, L. Huang, Z. Deng, B. Luo, Y. Cui, Drug nanocrystals: Surface engineering and its applications in targeted delivery, iScience 27 (2024) 111185. .10.1016/j.isci.2024.111185 ↗
58. Nanoparticle preparation of pharmaceutical compounds via wet milling: current status and future prospects10.1016/j.powtec.2024.119430 ↗
59. Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: insights for applications in HIV therapy10.1016/j.addr.2016.02.003 ↗
60. Design of nanocrystalline suspension of dutasteride for intramuscular prolonged delivery10.3390/nano14221781 ↗
61. Tuning physical properties of GelMA hydrogels through microarchitecture for engineering osteoid tissue10.1021/acs.biomac.3c00909 ↗
62. Injectable shear-thinning hydrogels for minimally invasive delivery to infarcted myocardium to limit left ventricular remodeling10.1161/CIRCINTERVENTIONS.116.004058 ↗
63. Mechanisms of degradation of collagen or gelatin materials (hemostatic sponges) in oral surgery: a systematic review10.3390/surgeries5030043 ↗
64. Nanosizing techniques for improving bioavailability of drugs10.1016/j.jconrel.2017.06.003 ↗
65. Local confinement controls diffusive nanoparticle dynamics in semidilute polyelectrolyte solutions10.1021/acs.langmuir.0c01402 ↗
66. Visualisation and quantification of subcutaneous injections of different volumes, viscosities and injection rates: an ex-vivo micro-CT study10.1016/j.xphs.2024.08.019 ↗
67. Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research10.1007/s40005-022-00584-w ↗
68. A new near-infrared fluorescence probe synthesized from IR-783 for detection and bioimaging of hydrogen peroxide in vitro and in vivo10.1016/j.saa.2021.120642 ↗
69. Gelatin methacryloyl hydrogel, from standardization, performance, to biomedical application10.1002/adhm.202300395 ↗
70. Gelatin methacryloyl (GelMA) loaded with concentrated hypoxic pretreated adipose-derived mesenchymal stem cells (ADSCs) conditioned medium promotes wound healing and vascular regeneration in aged skin10.1186/s40824-023-00352-3 ↗
71. Gelatin–based biomaterials and gelatin as an additive for chronic wound repair10.3389/fphar.2024.1398939 ↗
72. Control of matrix stiffness using methacrylate–gelatin hydrogels for a macrophage–mediated inflammatory response10.1021/acsbiomaterials.0c00295 ↗
73. Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing10.1038/s41467-024-50072-y ↗
74. Effect of tunable stiffness on immune responses in 3D‑bioprinted alginate–gelatin scaffolds10.36922/ijb.2874 ↗
75. Gelatin methacryloyl hydrogels for musculoskeletal tissue regeneration10.3390/bioengineering9070332 ↗
76. Self–aggregating long–acting injectable microcrystals10.1038/s44286-025-00194-x ↗
77. Effect of dispersion medium on pharmacokinetic profile of rotigotine crystalline suspension following subcutaneous injection10.3390/pharmaceutics14122630 ↗
78. Gelatin–based hydrogel degradation and tissue interaction in vivo: insights from multimodal preclinical imaging in immunocompetent nude mice10.7150/thno.16614 ↗
79. Multifunctional two–component in–situ hydrogel for esophageal submucosal dissection for mucosa uplift, postoperative wound closure and rapid healing
80. R.A. Al-Horani, P. Patel, Dutasteride, in: StatPearls [Internet], StatPearls Publishing, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK603726/.
81. A. Kumar, V. Gupta, S. Sharma, Donepezil, in: StatPearls [Internet], StatPearls Publishing, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513257/.
82. Crushed tablet administration for patients with dysphagia and enteral feeding: challenges and considerations10.1007/s40266-023-01056-y ↗
83. The psychological impacts of pill dysphagia: a mixed methods study10.1007/s00455-024-10703-4 ↗
84. A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease10.1080/14656566.2018.1480721 ↗
85. Rotigotine transdermal patch: a review in Parkinson’s disease10.1007/s40263-019-00646-y ↗
86. Challenges in the development of long acting injectable multivesicular liposomes (DepoFoam® technology)10.1016/j.ejpb.2024.114577 ↗